Drug Shortage Report for TRIFLUOPERAZINE
| Report ID | 228173 |
| Drug Identification Number | 00312746 |
| Brand name | TRIFLUOPERAZINE |
| Common or Proper name | Trifluperazine |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TRIFLUOPERAZINE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | N05AB |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-04-20 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-05-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-05-16 | French | Compare |
| v1 | 2024-05-16 | English | Compare |
Showing 1 to 2 of 2